Insmed (INSM) PT Raised to $195 at Truist Securities
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $123.98 --0%
Rating Summary:
32 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 8 | New: 26
Rating Summary:
32 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 8 | New: 26
Join SI Premium – FREE
Truist Securities analyst Danielle Brill raised the price target on Insmed (NASDAQ: INSM) to $195.00 (from $185.00) while maintaining a Buy rating.
You May Also Be Interested In
- Securitize Corp (SECZ) PT Raised to $12 at StoneX on 'Innovation Exemption'
- Lasertec Corp. (6920:JP) (LSRCF) PT Raised to JPY41,800 at Nomura/Instinet
- Takeda Pharmaceutical (4502:JP) (TAK) PT Raised to JPY7,000 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
